Related Experiment Videos
The detection, transmission, and outcome of hepatitis C virus infection
1Hepatitis Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333.
Insights
Hepatitis C virus (HCV) infection often leads to chronic liver disease. Current understanding suggests HCV may evade immune responses, hindering vaccine development and highlighting transmission prevention needs.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) is a primary cause of viral hepatitis, leading to chronic liver disease and cirrhosis globally.
- While percutaneous exposure is the most efficient transmission route, it accounts for less than half of reported cases, indicating other transmission pathways.
- Sexual, household, and perinatal transmission routes are suspected but their associated risks remain largely unknown.
Purpose of the Study:
- To summarize the global impact of Hepatitis C virus (HCV) infection.
- To investigate the transmission dynamics and immune evasion strategies of HCV.
- To highlight challenges in developing effective immunization and prevention strategies for Hepatitis C.
Main Methods:
- Literature review and synthesis of existing epidemiological data on HCV transmission.
- Analysis of human and chimpanzee study findings regarding HCV infection persistence and immune response.
- Evaluation of the implications for vaccine development and public health interventions.
Main Results:
- HCV infection frequently results in chronic liver disease (67% of cases), irrespective of the transmission source.
- HCV appears to evade a robust neutralizing antibody response, evidenced by high chronicity rates and lack of protection upon rechallenge in chimpanzees.
- Existing data indicates that less than half of reported cases are linked to percutaneous exposure, suggesting other routes are significant.
Conclusions:
- The high rate of chronic infection and HCV's apparent failure to elicit effective neutralizing antibodies pose significant challenges for developing vaccines.
- Understanding the factors facilitating HCV transmission is crucial for effective prevention strategies.
- Further research into non-percutaneous transmission routes and host-virus interactions is warranted.
Abstract:
Hepatitis C virus (HCV), the primary etiologic agent of parenterally transmitted non-A, non-B hepatitis, is a major cause of acute and chronic hepatitis and cirrhosis worldwide. The most efficient transmission of HCV is associated with percutaneous exposures to blood, but such exposures account for less than half of reported cases. Sexual, household, and perinatal transmission also seem to occur, but the risks associated with these types of exposures are still unknown. Virtually all persons with acute HCV infection seem to become chronically infected, and chronic liver disease with persistently elevated liver enzymes develops in an average of 67%, independent of the source for infection. The extraordinarily high rate of persistent infection observed in humans and the lack of protection against rechallenge with homologous HCV strains demonstrated in experimental studies in chimpanzees suggest that HCV fails to induce an effective neutralizing antibody response. This raises major concerns for the development of effective passive or active immunization against hepatitis C, and prevention may depend on a better understanding of the factors that facilitate the transmission of HCV infection.